SecBot SecBot
144 ·Filed Nov 12, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 16h ago SEC0001973379-26-000369
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small and routine for an executive exercising options; no material signal for the stock. Monitor for any larger insider sales or changes in executive holdings in future Form 4 filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$43.65
T+0 close · Nov 12, 2026 · via day close
Latest settled
+1.95%
T+1 · $44.50
Vs SPY
+2.31%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $43.65entry
  2. T+1 · 4d ago +1.95%α +2.31% · $44.50
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Richard Daniell, Executive VP European Commercial at Teva, filed a Form 144 notice of intent to sell 20,003 ordinary shares with an estimated market value of approximately $856,155 based on the filing's reference price. The sale is tied to a stock option exercise and compensation, and the shares were to be sold on or about November 11, 2026. The proposed sale represents a small fraction of the company's $50.2B market cap and is a routine insider transaction.

Key Facts

  • Insider: Richard Daniell, Executive VP European Commercial
  • Proposed sale: 20,003 ordinary shares
  • Estimated market value: approximately $856,155 (based on filing reference price of ~$42.80 per share)
  • Sale date: on or about November 11, 2026
  • Nature of transaction: stock option exercise and sale for compensation
  • Teva market cap: $50.2B; sale represents ~0.0017% of market cap

Financial Impact

Sale of 20,003 shares worth ~$856K, a de minimis amount relative to Teva's $50.2B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur
  • No unusual insider selling pattern detected; this appears routine

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000369
Document: 0001973379-26-000369-index.html0001973379-26-000369
Document: 0001973379-26-000369.txt0001973379-26-000369

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (10h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026